Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Masimo ( (MASI) ) has shared an update.
Masimo Corporation plans to engage with investors to reaffirm its financial outlook for fiscal 2025, as initially provided on May 6, 2025. The company is addressing a cybersecurity incident that may impact its operations, with potential legal, reputational, and financial risks, as well as possible regulatory inquiries and business disruptions.
The most recent analyst rating on (MASI) stock is a Buy with a $170.00 price target. To see the full list of analyst forecasts on Masimo stock, see the MASI Stock Forecast page.
Spark’s Take on MASI Stock
According to Spark, TipRanks’ AI Analyst, MASI is a Neutral.
Masimo’s overall stock score reflects a mixed outlook. Strong financial metrics are overshadowed by profitability challenges and valuation concerns. While technical indicators suggest neutral momentum, strategic shifts and optimistic earnings guidance offer potential upside.
To see Spark’s full report on MASI stock, click here.
More about Masimo
Masimo Corporation operates in the healthcare industry, primarily focusing on noninvasive monitoring technologies. The company is known for its innovative products that enhance patient care and safety, catering to a global market.
Average Trading Volume: 645,985
Technical Sentiment Signal: Sell
Current Market Cap: $8.14B
Find detailed analytics on MASI stock on TipRanks’ Stock Analysis page.